Diseases [C] » Immune System Diseases [C20] » Hypersensitivity » Hypersensitivity, Delayed
Description
An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. MeSH
Hierarchy View
Subtype Terms (6)
Acute Generalized Exanthematous Pustulosis
3 approved drugs
Dermatitis, Allergic Contact
38 drugs (20 approved, 18 experimental)
Drug Hypersensitivity Syndrome
9 drugs (8 approved, 1 experimental)
Sarcoidosis
55 drugs (42 approved, 13 experimental)
Stevens-Johnson Syndrome
18 drugs (16 approved, 2 experimental)
Phase 1 Indicated Drugs (3)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 2 Indications (1)
Organization Involved with Phase 1 Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
